- 2020.10.09 ユーグレナGENKIプログラムよりバングラデシュ事務所レポートを更新しました
- 2020.10.06 ジーンクエスト、湘南ヘルスイノベーションパークによる「周産期うつ病」をテーマとして発足した第3期湘南会議に参画
-
2020.10.06
(訂正)株主優待制度に関するお知らせ
We would like to inform you that the content of the preferential treatment system in the "Notice Concerning the Shareholder Benefit System" disclosed on August 21, 2020 has been partially changed due to the product renewal.
The corrected parts are marked with a red frame and double underlined.2. 2. Details of the shareholder benefit program
(2) Special treatment contents
A catalog where you can purchase the following products designated by us (1 product of 100 shares or more and less than 500 shares, 2 products of 500 shares or more) and products designated by us at a special discount price according to the number of shares you own. * Will be presented.
* Special discounts for shareholders are set for each product of health foods, cosmetics and gene analysis services listed in the catalog (10% discount is usually up to 30% discount for regular purchases of health foods and cosmetics). .. In addition, as an environmentally friendly initiative, we will abolish sending catalogs in paper booklets and guide you to browse online.<Before correction>
Over 100 shares:
"Euglena for the body Green Powder 1week" + Presentation of a catalog that allows you to purchase our designated products at a special discount price
Over 500 shares:
"Euglena for the body Green Powder 1week" and "Euglena for the body Green Tablet (28 tablets)" + Presentation of a catalog that allows you to purchase our designated products at a special discount price<After correction>
Over 100 shares:
"Euglena for the body Green Powder 1week" + Presentation of a catalog that allows you to purchase our designated products at a special discount price
Over 500 shares:
"Euglena for the body Green Powder 1week" and "Euglena for the body Green Tablet (42 tablets)" + Presentation of a catalog that allows you to purchase our designated products at a special discount price -
2020.09.29
理化学研究所とのユーグレナ遊泳不能変異体に関する共同研究の論文が、国際学術雑誌「PeerJ」に掲載されました
On September 28, 2020, Euglena non-swimming mutants was published in the international academic journal "PeerJ".
Using the method of inducing mutations in the Euglena genome by heavy ion beam irradiation, which was developed in collaboration with RIKEN, we will create a mutant that permanently lacks the swimming ability, which is one of the characteristics of Euglena I succeeded in doing so. In addition, through detailed analysis of the mutant, it was confirmed that Euglena
By utilizing the precipitation-prone property of this mutant, it is expected that not only the development that simplifies the harvesting process after culturing will be possible, but also that it will be a material that can be used for various academic research applications.
Click here for details (English treatise) -
2020.09.18
B.C.A.D.が「クリスタル アワード2020」化粧品部門トップスパコスメティックスを受賞しました
On September 16, 2020, the "Crystal Award 2020" (co-sponsored by Spa & Wellness Japan and Concept Asia Co., Ltd.) will be awarded to the facilities and brands that have gained the most support in the spa and wellness industry by voting by spa users. BCAD was selected as the top spa cosmetics in the cosmetics category.
In the top spa category, ANA Intercontinental Ishigaki Resort Spa Agarosa, who uses BCAD, has been selected as Japan's top spa.
Click here for details